This article is more than 5 years old. Information may no longer be current.

V Foundation presents grants to Vanderbilt researchers

Issue: December 25, 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The V Foundation for Cancer Research presented 2-year grant awards to two Vanderbilt-Ingram Cancer Center investigators.

Raymond Blind, PhD, assistant professor of medicine, biochemistry and pharmacology, received a grant to examine how proteins induce cancerous tumors to grow. His research is focused partly on liver cancer, rates of which are increasing among black and Hispanic individuals.

Raymond Blind

Justin Balko

Justin Balko, PharmD, PhD, assistant professor of medicine and cancer biology and leader of molecular oncology in the Center for Cancer Targeted Therapies, received a grant to determine what makes some therapies — particularly immunotherapies — more effective against cancer.

The V Foundation for Cancer Research is named after former college basketball coach Jim Valvano, who died of cancer in 1993. The foundation has awarded more than $150 million to cancer research and related programs.